A phase II trial of intravesical chemoimmunotherapy with gemcitabine and bacillus Calmette-Gu erin (BCG) for patients with BCG-exposed, high-grade, non-muscle-invasive bladder cancer.
JOURNAL OF UROLOGY（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要